December 22, 2021 – Commissioner’s order: Out of state licensed providers should read this memo from DPH Commissioner Manisha Juthani, MD and note the list of professions authorized by the Commissioner’s order

Connecticut Epidemiologist Newsletter   •   February 2021   •   Volume 41, No.2

 

Human Granulocytic Anaplasmosis—Connecticut, 2014–2019

Authors: T Eisenstein MPH, L Niccolai PhD ScM, S Niesobecki, Connecticut Emerging Infections Program at the Yale School of Public Health;  J Mullins DVM MPH PhD, Epidemiology and Emerging Infections Program, Connecticut Department of Public Health.

 

Human granulocytic anaplasmosis is a tickborne zoonosis caused by the bacterium Anaplasma phagocytophilum. In Connecticut, humans become infected through the bite of an infected blacklegged tick, Ixodes scapularis. Signs and symptoms of anaplasmosis are nonspecific and may include fever, chills, headache, and malaise (1). Although rare, severe illness or even death can occur. Common laboratory findings associated with anaplasmosis include thrombocytopenia, leukopenia, or increased levels of liver enzymes (1).

The Connecticut Department of Public Health (CTDPH) has conducted surveillance for anaplasmosis since 1995 (2). Through 2013, healthcare providers were required to provide clinical information by completing and returning a supplemental follow-up form sent to them by CTDPH. This clinical follow-up was discontinued in 2014 because response rates from providers were low and disease incidence was steady. Starting in 2014, laboratories were required to report only positive PCR results. For this report, a confirmed case was defined as having a positive A. phagocytophilum PCR.

From 20142019, 869 PCR positive cases of anaplasmosis were reported to CTDPH. During 2014–2018, an average of 111 cases were reported per year (range 88128), for an average annual statewide incidence rate of 3.1 per 100,000 persons. From 2018 to 2019, cases increased nearly threefold. In 2019, 315 cases of anaplasmosis were reported, for a statewide incidence rate of 8.8 cases per 100,000 persons.

During 20142019, the mean age of cases was 60.0 years (range 496), with 43.3% aged 50-69 years, followed by those ≥70 years (30.7%). The lowest proportion of cases was found in those <20 years of age (2.8%). The majority of cases were male (60%). The distribution of annual cases by age and gender was mostly consistent (Table).

From 20142018, nearly 67% of all cases were reported during June, July and August. Eleven percent were reported in May (Figure). Except for 2016, cases peaked in June and July each year; in 2016, the peak occurred in November. In 2019, cases also peaked in June and July, with a small second peak in November.

The spatial distribution of cases as indicated by zip code gradually shifted from the northeastern region of Connecticut to the western region. From 20142018, there was a higher proportion of cases with county of residence in Windham County (17.3%) compared to 2019 (1.9%). In 2014, 32.3% of cases were reported in Windham County. In 2019, most cases were reported in Fairfield (45.4%) and Litchfield (31.7%) counties.

Discussion

In 2019, there was a nearly 3-fold increase in the number of reported anaplasmosis cases compared to 20142018. While demographic and temporal trends were similar from year to year, there were notable changes in spatial distribution of cases by county and zip code of residence.

During 20142019, distribution of cases by age and gender parallel those previously reported by CTDPH and other health agencies (2,3).The higher number of cases observed in older age groups may reflect an association between disease severity and age and therefore increased testing in this population; during 20082012, national data showed hospitalizations, life-threatening complications, and case fatality rates increased with age (1).

The seasonal distribution of cases also mirrors what has been previously observed (3). Most reported cases of anaplasmosis occurred during summer months, resembling the temporal distribution of other tick-borne diseases transmitted by the same vector, such as Lyme disease. The peak in cases corresponds with the feeding stage of nymphal I. scapularis and increased outdoor human activity. The smaller fall peak that was observed in some years corresponds with adult tick activity (3).

Shifts in underlying environmental factors, such as forest fragmentation and climate change may impact habitat suitability for tick vectors and could have caused the shift in spatial distribution seen in 2019. It is also possible that the shift may be an artefact of case testing and reporting. Changes in provider ordering patterns could also account for differences in case counts in eastern and western Connecticut during 20142019.

Results may also reflect a true increase in cases. In recent years, health departments in other New England states also observed increases in anaplasmosis cases (4). Surveillance should include enhanced clinical follow-up, systematic active statewide tick surveillance to understand changes in distribution and abundance of I. scapularis, and pathogen testing of collected ticks to evaluate changes in the proportion carrying A. phagocytophilum. The Connecticut Agricultural Experiment Station has conducted passive tick surveillance since 1990 and began active statewide surveillance in 2019 (5).

Key Messages for Providers

In 2020, clinical follow-up conducted by CTDPH resumed. Healthcare providers’ assistance in collecting clinical data for anaplasmosis is critical to further characterize the full clinical spectrum and epidemiology of this disease in Connecticut. Providers should be aware of the increased incidence of anaplasmosis during summer months and late fall and remain cognizant that symptoms of anaplasmosis pose similarities to those of other diseases, including COVID-19 and influenza.

References
  1. Dahlgren S, Heitman KN, Drexler NA, et.al. Human Granulocytic Anaplasmosis in the United States from 2008 to 2012: A Summary of National Surveillance Data. Am. J. Trop. Med. Hyg.,93(1), 6672. https://www.ajtmh.org/view/journals/tpmd/93/1/article-p66.xml. Accessed January 10, 2021.
  2. Connecticut Department of Public Health. Anaplasmosis Connecticut, 20112014. Connecticut Epidemiologist, 35(5), 1718. https://portal.ct.gov/-/media/Departments-and-Agencies/DPH/dph/infectious_diseases/CTEPINEWS/Vol35No5pdf.pdf. Accessed January 10, 2021.
  3. Centers for Disease Control and Prevention. (2019). Anaplasmosis epidemiology and statistics. https://www.cdc.gov/anaplasmosis/stats/index.html. Accessed January 10,2021.
  4. Elias SP, Bonthius J, Robinson S, et. al. Surge in Anaplasmosis Cases in Maine, USA, 20132017. Emerging Infectious Diseases, 26(2), 327331. https://dx.doi.org/10.3201/eid2602.190529. Accessed January 10, 2021.
  5. Connecticut Agricultural Experiment Station. The Connecticut Agricultural Experiment Station announces a new tick surveillance program for Connecticut. [Press release]. https://portal.ct.gov/-/media/CAES/DOCUMENTS/Publications/Press_Releases/2019/CAES_4_11_2019-Press-Release-Tick-Surveillance.pdf. Accessed January 10, 2021.

 

Table of demographic information for anaplasmosis cases reported in Connecticut from 2014-2019.

Bar graph of total number of reported anaplasmosis cases by in Connecticut from 2014-2019.

 

 

This page last updated 02/23/2021.